Federal Register Notice: FDA is requesting that patient stakeholders notify the agency by 10/3 of their intention to participate in periodic consultation meetings on process issues related to FDA’s patient-focused drug development initiative. The meetings will address establishing a process for conducting a series of patient-focused drug development meetings that will be useful to both the patient community and FDA. To view this notice, click here.
